Pyridazinone derivatives
US8207168B2 · kind B2 · utility
2Cited by
25References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 15, 2010 |
| Grant date | Jun 26, 2012 |
| Priority date | — |
| Expiry date | Sep 8, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel pyridazinone derivatives that mediate enzymatic activity. In particular, the compounds may be effective in the treatment of diseases or disease states related to the activity of the histamine H3 receptor, including, for example, neurodegenerative disorders, sleep/wake disorders, attention deficit hyperactivity disorder and cognition disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.